These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22740926)

  • 1. Association of NAT2 phenotype with risk of head and neck carcinoma: A meta-analysis.
    Zheng Y; Li Y; Teng Y; Zhang Z; Cao X
    Oncol Lett; 2012 Feb; 3(2):429-434. PubMed ID: 22740926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetyltransferase 2 phenotype and risk of esophageal cancer: a meta analysis.
    Ma RL; Min L; Chen D; Tao WP; Ge W; Wu YG
    Cancer Biomark; 2013 Jan; 13(6):447-55. PubMed ID: 24595082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of
    Mohammadi H; Roochi MM; Sadeghi M; Garajei A; Heidar H; Ghaderi B; Tadakamadla J; Meybodi AA; Dallband M; Mostafavi S; Mostafavi M; Salehi M; Sadeghi-Bahmani D; Brand S
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684132
    [No Abstract]   [Full Text] [Related]  

  • 4. NAT2 polymorphism and gastric cancer susceptibility: a meta-analysis.
    Zhong X; Hui C; Xiao-Ling W; Yan L; Na L
    Arch Med Res; 2010 May; 41(4):275-80. PubMed ID: 20637371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of association between N-acetyltransferase 2 acetylator status and colorectal cancer susceptibility: based on evidence from 40 studies.
    Zhang Lq; Zhou Jn; Wang J; Liang Gd; Li Jy; Zhu Yd; Su Yt
    PLoS One; 2012; 7(3):e32425. PubMed ID: 22403658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis.
    Ying XJ; Dong P; Shen B; Wang J; Wang S; Wang G
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1661-7. PubMed ID: 21877196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
    Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
    Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
    Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
    J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.
    Wu H; Wang X; Zhang L; Mo N; Lv Z
    Clin Genitourin Cancer; 2016 Apr; 14(2):122-9. PubMed ID: 26585839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of the relationship between NAT2 polymorphism and colorectal cancer susceptibility.
    Liu H; Fu ZX; Wang CY; Qian J; Xing L; Liu YW
    Medicina (Kaunas); 2012; 48(3):117-31. PubMed ID: 22588343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between N-acetyltransferase 2 polymorphisms and pancreatic cancer risk: a meta-analysis.
    Liang JX; Gao W; Liang Y; Zhou XM
    Genet Mol Res; 2015 Dec; 14(4):17219-27. PubMed ID: 26681215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between NAT2 acetylator status and adverse drug reactions of sulfasalazine: a systematic review and meta-analysis.
    Yee J; Kim SM; Han JM; Lee N; Yoon HY; Gwak HS
    Sci Rep; 2020 Feb; 10(1):3658. PubMed ID: 32107440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAT2 polymorphism and lung cancer risk: a meta-analysis.
    Cui D; Wang Z; Zhao E; Ma J; Lu W
    Lung Cancer; 2011 Aug; 73(2):153-7. PubMed ID: 21292342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes.
    Doll MA; Hein DW
    Arch Toxicol; 2017 Jul; 91(7):2655-2661. PubMed ID: 28516247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma.
    Betti M; Neri M; Ferrante D; Landi S; Biava A; Gemignani F; Bertolotti M; Mirabelli D; Padoan M; Ugolini D; Botta M; Bonassi S; Magnani C; Dianzani I
    Int J Hyg Environ Health; 2009 May; 212(3):322-9. PubMed ID: 18838334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyltransferase 2 acetylator genotype-dependent N-acetylation of 4-aminobiphenyl in cryopreserved human hepatocytes.
    Habil MR; Doll MA; Hein DW
    Pharmacogenet Genomics; 2020 Apr; 30(3):61-65. PubMed ID: 31895247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis.
    Suvichapanich S; Fukunaga K; Zahroh H; Mushiroda T; Mahasirimongkol S; Toyo-Oka L; Chaikledkaew U; Jittikoon J; Yuliwulandari R; Yanai H; Wattanapokayakit S; Tokunaga K
    Pharmacogenet Genomics; 2018 Jul; 28(7):167-176. PubMed ID: 29781872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.
    Hein DW
    Mutat Res; 2002 Sep; 506-507():65-77. PubMed ID: 12351146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population.
    Marcus PM; Vineis P; Rothman N
    Pharmacogenetics; 2000 Mar; 10(2):115-22. PubMed ID: 10761999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.